Business Standard

Market hits fresh intraday low

Image

Capital Market

Key benchmark indices extended intraday losses to hit fresh intraday low in afternoon trade as weak start for the trade of European markets weighed on sentiment. The barometer index, the S&P BSE Sensex, was down 107.56 points or 0.52%, off close to 160 points from the day's high and up about 10 points from the day's low. The market breadth, indicating the overall health of the market was negative.

Capital goods stocks edged lower on worries the ongoing slowdown in the economy could restrict new orders. Bank stocks fell across the board. Sun Pharmaceutical Industries surged after good Q4 result and a liberal 1:1 bonus issue announced after market hours on Tuesday, 28 May 2013.

 

Key benchmark indices reversed direction after a positive start. The barometer index, the BSE Sensex, hit its highest level in a week at the onset of the trading session. Key benchmark indices cut losses in morning trade. Key benchmark indices hovered in red in mid-morning trade. A bout of volatility was witnessed in early afternoon trade as key benchmark indices trimmed losses after hitting fresh intraday low in early afternoon trade. The market extended losses to hit fresh intraday low in afternoon trade.

The market may remain volatile in the near future as traders roll over positions in the futures & options (F&O) segment from the near-month May 2013 series to June 2013 series. The May 2013 derivatives contracts expire tomorrow, 30 May 2013.

At 13:20 IST, the S&P BSE Sensex was down 107.56 points or 0.52% to 20,056.75. The index gained 55.67 points at the day's high of 20,216.49 in early trade, its highest level since 22 May 2013. The index fell 116.08 points at the day's low of 20,044.74 in afternoon trade.

The CNX Nifty was down 40.90 points or 0.67% to 6,070.35. The index hit a low of 6,069.80 in intraday trade. The index hit a high of 6,125.05 in intraday trade.

The market breadth, indicating the overall health of the market was negative. On BSE, 1,236 shares declined and 866 shares gained. A total of 144 shares were unchanged.

Among the 30-share Sensex pack, 22 stocks declined and the rest of them gained. Tata Steel, Jindal Steel & Power and Sterlite Industries were down by 2.06% to 2.57%.

Capital goods stocks edged lower on worries the ongoing slowdown in the economy could restrict new orders. Punj Lloyd, Siemens and Thermax shed by 0.38% to 2.77%.

Bharat Heavy Electricals (Bhel) declined 2.03%. Bhel's net profit fell 4.2% to Rs 3237.54 crore on 2.2% decline in net sales to Rs 18850.16 crore in Q4 March 2013 over Q4 March 2012. The company reported Q4 results during market hours on 23 May 2013.

L&T dropped 0.95%. The company reported 6.9% fall in net profit to Rs 1787.94 crore on 9.9% rise in total income to Rs 20686.93 crore in Q4 March 2013 over Q4 March 2012. The result was announced on 22 May 2013.

Bank stocks fell across the board. State Bank of India (SBI) declined 0.86%.

Among other PSU bank stocks, Canara Bank, Union Bank of India, Bank of India, Bank of Baroda and Punjab National Bank dropped by 0.57% to 2.69%.

ICICI Bank fell 1.13% to Rs 1,216.40. The stock had hit 52-week high of Rs 1,236.90 in intraday trade on Tuesday, 28 May 2013.

HDFC Bank shed 1.04% to Rs 706. The stock had hit a record high of Rs 724 hit in intraday trade on 20 May 2013.

Induslnd Bank fell 0.78%. The bank and American Express during market hours today, 29 May 2013 announced strategic partnership with the launch of the new Induslnd Bank Iconia American Express Card. This is IndusInd Bank's first American Express-branded credit card product.

Sun Pharmaceutical Industries galloped 7.59% to Rs 1,071.10 after striking a record high of Rs 1,079.90 in intraday trade today, 29 May 2013. The company's consolidated net profit rose 23.3% to Rs 1011.56 crore on 31.8% rise in net sales to Rs 3071.49 crore in Q4 March 2013 over Q4 March 2012. The company announced its Q4 results after market hours on Tuesday, 28 May 2013.

Sun Pharmaceutical Industries said that the board of directors of the company at its meeting held on Tuesday, 28 May 2013, has recommended a liberal 1:1 bonus issue.

Sun Pharmaceutical Industries' consolidated earnings before interest, taxes, depreciation and amortization (EBITDA) grew by 32% to Rs 1260 crore in Q4 March 2013 over Q4 March 2012, while sustaining EBITDA margin at 41%.

Sun Pharmaceutical Industries said that branded generic sales in India were at Rs 780 crore. Adjusted for the extra sales recorded in the Q4 March 2012, as well as the change in treatment of expected sales returns and treatment of discounts, the underlying sales growth of the domestic formulation business is 16%.

US finished dosage sales grew by 63% to $330 million in Q4 March 2013 over Q4 March 2012. International formulation sales grew by 13% to $73 million in Q4 March 2013 over Q4 March 2012.

Consolidated research and development (R&D) expense for Q4 March 2013 was Rs 203 crore, at 6.6% of sales. For the year ended March 2013 (FY 2013), R&D spend was Rs 676 crore, at 6% of sales.

Dilip Shanghvi, managing director of the company said, "I am very pleased to announce that, our sales for FY 2013 have crossed the $2 billion mark. While it took us almost 27 years to record $1 billion in revenues, the next billion was added in just 3 years."

He further said, "All our businesses continue to perform in-line with our expectations. We continue to focus on building a differentiated and specialty product portfolio and enhancing our international presence. Overall, we shall strive to remain focused on execution and building a business with consistent performance."

Meanwhile, Sun Pharma has declined to comment on market speculation that the company may acquire Germany-based Stada.

The Q4 March 2013 earnings season gets over this week. DLF, M&M and Tata Power unveil Q4 results tomorrow, 30 May 2013.

On the macro front, the government will announce Q4 March 2013 gross domestic product (GDP) data on Friday, 31 May 2013. India's GDP grew 4.5% in Q3 December 2012, sharply slower than the 5.3% expansion reported for Q2 September 2012.

The Reserve Bank of India (RBI) undertakes mid-quarter review of the monetary policy on 17 June 2013. RBI Governor D Subbarao on 14 May 2013 said that the central bank will take note of falling inflation when discussing potential interest rate cuts. The RBI on 3 May 2013 cut its key policy rate viz. the repo rate by 25 basis points (bps) to 7.25% and kept the cash reserve ratio (CRR) for banks unchanged at 4% after a monetary policy review. RBI said at that time that the balance of risks stemming from its assessment of the growth-inflation dynamic provides little space for further monetary easing. The RBI said it will endeavour to condition the evolution of inflation to a level of 5% by March 2014, using all instruments at its command.

The finance ministry in October 2012 announced a five-year plan to cut fiscal deficit. The government hopes to reduce the fiscal deficit to 3% by March 2017.

European stocks retreated on Wednesday as encouraging US economic data sparked worries that it could trigger the US Federal Reserve to taper its aggressive bond-purchasing program. Key benchmark indices in France, Germany and UK dropped by 0.65% to 0.99%.

Asian shares were mostly higher on Wednesday as US stocks rallied to record highs overnight. Key benchmark indices in Japan, Taiwan, Indonesia, South Korea, and China rose by 0.1% to 0.91%. Key benchmark indices in Singapore and Hong Kong fell by 0.67% to 1.58%.

The International Monetary Fund cut its growth forecast for China this year to 7.75% from 8%, citing a weak world economy and exports, adding to concerns that the world's second-largest economy is losing momentum.

Trading in US index futures indicated that the Dow could fall 48 points at the opening bell on Wednesday, 29 May 2013. US stocks climbed on Tuesday, bouncing back from last week's losses after data showed consumer confidence rising in May and the real-estate market picking up speed.

Last week, Fed Chairman Ben Bernanke said the central bank could start to reduce its stimulus program in coming months if data continue to improve, stoking fears of market turmoil.

Powered by Capital Market - Live News

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 29 2013 | 1:21 PM IST

Explore News